Published in Vaccine Weekly, August 2nd, 2006
Study 1: Concurrent administration of measles-mumps-rubella, varicella, and Haemophilus influenzae type b vaccines with a fourth dose of heptavalent pneumococcal conjugate vaccine is safe and efficacious.
"Prevnar [heptavalent pneumococcal conjugate vaccine (PCV7)] is licensed in the United States for routine administration in infants and may be co-administered with other infant vaccines. Safety and immunogenicity data on the co-administration of the fourth dose of PCV7 with measles-mumps-rubella (MMR), varicella and Haemophilus influenzae type b (Hib) vaccines...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly